Methylprednisolone Induce Terminal Differentiation in the U-937 Human Myelomonocytic Leukemia Cells

Ozclmen A. A., ÇETİN M.

TURKISH JOURNAL OF IMMUNOLOGY, vol.13, no.1, pp.10-14, 2008 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 1
  • Publication Date: 2008
  • Journal Name: TURKISH JOURNAL OF IMMUNOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.10-14
  • Hacettepe University Affiliated: Yes

Abstract

Differentiation studies have shown that methylprednisolone have some roles onto the leukemia cell line such as HL-60 and K-562. Methylprednisolone (MP), a steroid compound, binds the nuclear glucocorticoid receptor and regulates the transcription. In this study, differentiation effect of methylprednisolone on human monocytic leukemia (U-937) cell line was investigated for two types of cluster differentiation (CD11b, CD68) markers by using flow cytometry. It was observed that the significant terminal differentiation of U-937 cells occured after treatment with high dose (10-3 M) MP for 24 and 48 hrs. Our data points out that MP is a differentiation inducing agent for myelomonocytic leukemic cells and could be potential treating compound in other type of leukemic cell differentiation.